)
Visual24 Oct 2025
The rise of Alphabet
Ryvu Therapeutics (RVU) investor relations material
Ryvu Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary18 Sep, 2025
Executive summary
Operating revenue for H1 2025 was PLN 42.4M, down from PLN 48.5M year-over-year, mainly due to lower R&D project revenues and the absence of a milestone payment received in H1 2024.
Net loss increased to PLN 58.9M from PLN 49.8M year-over-year, driven by lower revenues and a negative impact from NodThera share valuation, partially offset by a positive put option effect.
Strategic reorganization, including a 30% workforce reduction and pipeline adjustments, was implemented to extend the cash runway to H2 2026 and focus on RVU120 and early pipeline development.
Financial highlights
Total assets as of June 30, 2025, were PLN 281.2M, down from PLN 378.8M at year-end 2024, mainly due to R&D expenditures.
Cash and cash equivalents stood at PLN 107.2M, with additional financial assets of PLN 48.9M.
Total liabilities increased to PLN 185.9M, with long-term liabilities at PLN 116.2M, mainly from EIB loans.
Net cash outflow from operating activities was PLN 68.6M; investing activities generated PLN 18.2M, and financing activities used PLN 2.2M.
Book value per share was PLN 4.12, down from PLN 8.88 at year-end 2024.
Outlook and guidance
Cash position and EIB financing support ongoing operations and planned investments, with a cash runway extended to H2 2026.
Future revenues depend on successful commercialization of R&D projects and achieving milestones in collaborations.
Key objectives include advancing RVU120 clinical development, supporting partnered candidate SEL24, and progressing preclinical programs.
Reorganization impact on pipeline pace?
RVU120: Refined clinical strategy?
BioNTech partnership: Strategic alignment?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Ryvu Therapeutics earnings date
Q3 202520 Nov, 2025
Next Ryvu Therapeutics earnings date
Q3 202520 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Ryvu Therapeutics S.A. is a Poland-based biotechnology company focused on the research and development of novel small molecule therapies. The company specializes in discovering and developing treatments for cancer, particularly in the areas of targeted therapies and immuno-oncology. Ryvu conducts both early-stage discovery and clinical development activities, with a pipeline supported by internal research capabilities and collaborative partnerships. The company is headquartered in Kraków, Poland, and its shares are listed on the WSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage